| Metric | This Period | Prior Year Same Period | YoY |
|---|---|---|---|
| Revenue | ¥180.7B | ¥126.1B | +43.3% |
| Operating Income | ¥5.8B | ¥5.0B | +14.7% |
| Ordinary Income | ¥7.8B | ¥6.6B | +18.0% |
| Net Income | ¥18.0B | ¥15.8B | +14.2% |
| ROE | 10.0% | 11.6% | - |
FY2026 Q2 results: Revenue ¥180.7B (YoY +¥54.6B +43.3%), Operating Income ¥5.8B (YoY +¥0.7B +14.7%), Ordinary Income ¥7.8B (YoY +¥1.2B +18.0%), Net Income ¥18.0B (YoY +¥2.2B +14.2%). Revenue expanded sharply driven by volume increases, but gross margin fell to 10.7% (down 2.2pt from 12.9% a year earlier), reducing profitability; SG&A increases kept Operating Margin at 3.2% (down 0.8pt from 4.0%). Extraordinary gains ¥16.6B (primarily gain on sale of investment securities) supported Net Income, but Operating Cash Flow was ¥-7.7B (significantly worse than prior year ¥+5.8B), showing a steep decline in cash-generating capability. The company retains very strong liquidity with investment securities ¥107.4B and cash ¥77.5B, but the combination of negative Operating Cash Flow and a Payout Ratio of 67.3% warrants attention from a dividend sustainability perspective.
[Revenue] Revenue expanded sharply to ¥180.7B (YoY +43.3%). Although segment disclosure is not provided, the ¥54.6B YoY increase is presumed to stem from higher shipments of existing products and acquisition of new demand. Non-operating income ¥2.2B (mainly dividend income ¥2.0B) is stable but limited at 1.2% of revenue. Extraordinary gains ¥16.6B (gain on sale of investment securities ¥16.6B) lifted Profit Before Tax to ¥24.3B.
[Profitability] Gross profit was ¥19.4B with a gross margin of 10.7% (down 2.2pt from 12.9%). Increases in raw material and manufacturing costs and delays in passing on price increases appear to have pressured margins. SG&A was ¥13.6B (up 20.4% from ¥11.3B a year earlier), growing well below revenue growth, so operating leverage did not materialize. As a result, Operating Income remained ¥5.8B (+14.7%), with an Operating Margin of 3.2% (down 0.8pt from 4.0%). Ordinary Income ¥7.8B (+18.0%) exceeded Operating Income due to stable non-operating income, but Net Income ¥18.0B (+14.2%) was heavily dependent on the extraordinary gain of ¥16.6B, highlighting weakness in recurring earnings. After income taxes of ¥6.3B, Net Margin was 10.0% (down 2.5pt from 12.5%). Overall, revenue growth was offset by rising costs.
[Profitability] Operating Margin 3.2% (prior year 4.0%), Net Margin 10.0% (prior year 12.5%). The decline in Gross Margin to 10.7% (prior year 12.9%) is the primary driver of compressed Operating Margin. ROE 10.0% (prior year 11.3%) remains at a healthy level, but calculated as Net Margin 10.0% × Total Asset Turnover 0.83 × Financial Leverage 1.20x, the fall in Net Margin reduced contribution. [Cash Quality] Operating Cash Flow -¥7.7B, Operating CF/Net Income -0.43x indicates deterioration in cash quality. Increases in Accounts Receivable +¥7.4B and Inventory +¥0.9B and corporate tax payments -¥8.0B were primary drivers. OCF/EBITDA -1.16x shows weak cash conversion. [Investment Efficiency] Total Asset Turnover 0.83x (prior year 0.80x) improved. Investment securities ¥107.4B account for 49.4% of total assets, making the asset base sensitive to market conditions. Capital expenditures ¥0.7B and depreciation ¥0.9B yield CapEx/Depreciation 0.79x, indicating restrained investment. [Financial Soundness] Equity Ratio 83.1% (prior year 85.2%), Current Ratio 1567%—extremely healthy. Debt-to-equity 0.20x and cash ¥77.5B far exceed short-term debt ¥6.8B, minimizing maturity mismatch risk. Deferred tax liabilities ¥27.7B arise from valuation differences on investment securities, posing equity erosion risk if market values decline.
Operating Cash Flow was -¥7.7B (worsening ¥13.5B from prior year +¥5.8B), representing -0.43x of Net Income ¥18.0B and raising quality concerns. Operating cash flow before working capital changes was -¥1.5B, and working capital changes produced a net cash outflow of -¥6.9B driven by Accounts Receivable increase -¥7.4B (extended collection terms amid rapid sales growth), Inventory increase -¥0.9B (stock build for demand) and Accounts Payable increase +¥0.5B (slight extension of payment terms). Corporate tax payments -¥8.0B further weighed on cash, leaving OCF/EBITDA at -1.16x and highlighting weak conversion. Investing Cash Flow was +¥11.1B, led by proceeds from sale of investment securities ¥17.4B, net of CapEx -¥0.7B and purchase of securities -¥0.1B. Free Cash Flow was ¥3.4B but insufficient to cover dividend payments ¥7.3B (full-year assumption), resulting in Financing Cash Flow -¥6.7B (dividends -¥7.3B, treasury stock purchase -¥0.0B, disposal of treasury stock +¥0.6B). Cash decreased ¥3.3B year-over-year to ¥77.5B but liquidity remains ample. Going forward, accelerating receivables collection, normalizing inventory turnover, and smoothing tax effects to restore Operating Cash Flow are key to dividend sustainability.
Ordinary Income ¥7.8B versus Net Income ¥18.0B shows a 2.3x gap, revealing heavy reliance on extraordinary gains ¥16.6B (gain on sale of investment securities). Non-operating income ¥2.2B (dividend income ¥2.0B, foreign exchange gains, etc.) is stable but limited at 1.2% of revenue. Non-operating expenses ¥0.2B (fees) are minor. From an accrual perspective, the divergence between Operating Cash Flow -¥7.7B and Net Income ¥18.0B (-¥25.7B) is significant, mainly due to working capital increases Accounts Receivable +¥7.4B, Inventory +¥0.9B and corporate tax payments -¥8.0B. The extraordinary gain ¥16.6B is one-off; recurring earning power is concentrated in Operating Income ¥5.8B (Operating Margin 3.2%). The buildup of Deferred Tax Liabilities ¥27.7B stems from unrealized gains on investment securities and poses valuation difference risk in market downturns.
Full-year plan (Revenue ¥240.0B, Operating Income ¥6.1B, Ordinary Income ¥8.0B, Net Income ¥21.7B): as of Q2, progress rates are Revenue 75%, Operating Income 95%, Ordinary Income 98%, Net Income 83%—ahead of schedule. Operating and Ordinary Income are nearly meeting full-year plans, and with the contribution of Extraordinary Gains ¥16.6B Net Income has reached 83% of plan. However, Gross Margin 10.7% and Operating Margin 3.2%—while slightly better than plan (Operating Margin assumed around 2.5%)—the negative Operating Cash Flow -¥7.7B and weak cash generation suggest risk to delivering the plan. Full-year EPS forecast ¥373.93 versus Q2 realized EPS ¥311.86 (83% progress) is on track, but improvements in second-half profitability and normalization of cash flows are prerequisites for meeting full-year targets.
Interim dividend was ¥63, year-end planned ¥137, total ¥200 per share—significantly exceeding the full-year plan of ¥115 per share. Payout Ratio is 67.3% (Dividend ¥200 ÷ EPS ¥297.0) which is relatively high. Free Cash Flow ¥3.4B versus dividend payments ¥7.3B (full-year assumption) yields FCF coverage 0.47x, meaning dividends cannot be covered by internal funds alone. However, cash ¥77.5B and strong liquidity mean there is no short-term issue in paying dividends. Treasury stock purchases were -¥0.0B (effectively zero), so Total Return Ratio equals the Payout Ratio. Given the risk of continued negative Operating Cash Flow, medium-term dividend sustainability depends on recovery of core earnings and OCF, and on reducing reliance on gains from sale of investment securities.
Low gross margin structure risk: Gross Margin 10.7% (down 2.2pt from 12.9%) makes earnings highly sensitive to increases in raw material and manufacturing costs. SG&A ¥13.6B (7.5% of revenue) consumes 70% of gross profit, limiting operating leverage. Delays in price pass-through or product-mix improvement could further depress Operating Margin from the current 3.2%.
Operating CF deterioration risk: Operating CF -¥7.7B (OCF/Net Income -0.43x) with working capital expansion Accounts Receivable +¥7.4B and Inventory +¥0.9B continuing. If extended collection terms and inventory buildup become persistent with rapid sales growth, cash generation could deteriorate structurally. FCF ¥3.4B cannot cover dividends ¥7.3B, making OCF recovery essential for sustained returns.
Investment securities dependence risk: Investment securities ¥107.4B (49.4% of total assets) with Deferred Tax Liabilities ¥27.7B accumulated. Market downturns could shrink valuation differences, erode equity, and reduce Deferred Tax Liabilities, shrinking the balance sheet. Dependence on Extraordinary Gains ¥16.6B is temporary and exposes the weakness of recurring earnings.
Profitability & Return
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Operating Margin | 3.2% | 7.8% (4.6%–12.3%) | -4.6pt |
| Net Margin | 10.0% | 5.2% (2.3%–8.2%) | +4.8pt |
Operating Margin is 4.6pt below the industry median (placing the company in the lower ranks), while Net Margin is 4.8pt above the median due to contribution from extraordinary gains.
Growth & Capital Efficiency
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Revenue Growth Rate (YoY) | 43.3% | 3.7% (-0.4%–9.3%) | +39.6pt |
Revenue growth markedly outpaces the industry median by 39.6pt, placing the company among the leaders in growth pace.
※ Source: Company compilation
The biggest highlight is the weak profitability: Operating Margin 3.2% versus industry median 7.8% (down 4.6pt). Low Gross Margin 10.7% and heavy SG&A at 7.5% of sales (70% of gross profit) impede operating leverage. Recovery of core margins via price adjustments, product-mix improvement, and manufacturing efficiency is essential; observing a trend reversal in Gross Margin and Operating Margin over coming quarters will be critical.
Operating CF -¥7.7B (OCF/Net Income -0.43x) shows a steep decline in cash generation; FCF ¥3.4B cannot cover dividends ¥7.3B. Working capital expansion Accounts Receivable +¥7.4B and Inventory +¥0.9B are main drivers, so faster receivables collection and improved inventory turnover to normalize OCF are prerequisites for dividend sustainability. Cash ¥77.5B provides short-term buffer, but medium-term requires simultaneous improvement in core earnings and cash flow.
Most of Net Income ¥18.0B is attributable to Extraordinary Gains ¥16.6B (gain on sale of investment securities); recurring earnings are concentrated in Operating Income ¥5.8B (Operating Margin 3.2%). The mix of Investment Securities ¥107.4B (49.4% of assets) and Deferred Tax Liabilities ¥27.7B embeds balance sheet volatility risk with market fluctuations. Eliminating reliance on one-off gains and shifting to stable growth on an operating-income basis are structural issues highlighted by the results.
This report was generated by AI analyzing XBRL financial statement data to produce an automated earnings analysis. It is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled by the company based on public financial statements. Investment decisions should be made at your own responsibility; consult a professional advisor as needed.